Live Breaking News & Updates on Asterias Biotherapeutics

Stay updated with breaking news from Asterias biotherapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Asterias Biotherapeutics (NYSEAMERICAN:AST) Shares Down 1.1%

Shares of Asterias Biotherapeutics Inc (NYSEAMERICAN:AST – Get Rating) were down 1.1% on Monday . The stock traded as low as $0.90 and last traded at $0.94. Approximately 99,200 shares changed hands during trading, a decline of 27% from the average daily volume of 136,653 shares. The stock had previously closed at $0.95. Asterias Biotherapeutics […] ....

Asterias Biotherapeutics , Asterias Biotherapeutics Inc , Get Rating , Nyseamerican Ast ,

Class, Biotech Co. Propose $10.65M Deal To End Merger Suit

Former Asterias Biotherapeutics stockholders have reached a $10.65 million deal to settle a 3-year-old Delaware Chancery Court class action challenging the company's November 2018 stock-for-stock merger agreement with allegedly controlling investor BioTime Inc. ....

United States , Asterias Biotherapeutics , Biotime Inc , Delaware Chancery Court , Jeff Montgomery ,